The selective mGluR5 agonist CHPG protects against traumatic brain injury in vitro and in vivo via ERK and Akt pathway
about
Erythropoietin: new directions for the nervous systemPostsynaptic scaffold protein Homer 1a protects against traumatic brain injury via regulating group I metabotropic glutamate receptors.Ginsenoside Rd attenuates mitochondrial permeability transition and cytochrome C release in isolated spinal cord mitochondria: involvement of kinase-mediated pathways.Activation of mGluR5 attenuates NMDA-induced neurotoxicity through disruption of the NMDAR-PSD-95 complex and preservation of mitochondrial function in differentiated PC12 cells.Decreased level of olfactory receptors in blood cells following traumatic brain injury and potential association with tauopathyInvolvement of metabotropic glutamate receptor 5, AKT/PI3K signaling and NF-κB pathway in methamphetamine-mediated increase in IL-6 and IL-8 expression in astrocytes.Regeneration in the nervous system with erythropoietinMicroglia in the TBI brain: The good, the bad, and the dysregulated.Oxidant stress and signal transduction in the nervous system with the PI 3-K, Akt, and mTOR cascadeActivation of mGluR5 and inhibition of NADPH oxidase improves functional recovery after traumatic brain injuryNovel mGluR5 positive allosteric modulator improves functional recovery, attenuates neurodegeneration, and alters microglial polarization after experimental traumatic brain injury.Metabotropic glutamate receptor 5 deficiency inhibits neutrophil infiltration after traumatic brain injury in mice.mGluR5 protect astrocytes from ischemic damage in postnatal CNS white matter.The Orally Active Noncompetitive AMPAR Antagonist Perampanel Attenuates Focal Cerebral Ischemia Injury in Rats.
P2860
Q26828425-47FD9763-8EAF-402C-AC94-744E75238451Q33654169-2A2897A0-5FF5-4233-862A-59117A65398AQ33907618-D699730F-A3C8-4E6E-A340-8B2B73533B9DQ33907912-5F4DCD2C-AD77-4BBF-940F-B66081AE83F1Q34317749-3EDED22F-216D-4ACF-8481-75FCF7915085Q35917735-15794053-3279-485F-912E-981C746151EDQ36247651-DFD5DFB2-A94D-4DA3-80B2-8920A1AED86CQ36399682-37135BD9-E542-45F1-B43A-F0FE6FD543FFQ36432388-FF1CC675-1C53-4363-9BDC-7A6F03C1F0D8Q36661183-0F9F5E8A-2DA2-4209-98B5-8B31B970429DQ39445567-7148034B-3EA4-4D19-90C8-96E6F72D9C74Q41564939-A01A63DD-EE03-46F1-880B-ADC0769AC7BFQ43186779-96901B81-7D57-4E55-97BB-893EB0DB99BAQ52098933-259C7926-BAF5-498B-AD2A-653EF8A5DBA2
P2860
The selective mGluR5 agonist CHPG protects against traumatic brain injury in vitro and in vivo via ERK and Akt pathway
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The selective mGluR5 agonist C ...... n vivo via ERK and Akt pathway
@ast
The selective mGluR5 agonist C ...... n vivo via ERK and Akt pathway
@en
type
label
The selective mGluR5 agonist C ...... n vivo via ERK and Akt pathway
@ast
The selective mGluR5 agonist C ...... n vivo via ERK and Akt pathway
@en
prefLabel
The selective mGluR5 agonist C ...... n vivo via ERK and Akt pathway
@ast
The selective mGluR5 agonist C ...... n vivo via ERK and Akt pathway
@en
P2093
P2860
P356
P1476
The selective mGluR5 agonist C ...... n vivo via ERK and Akt pathway
@en
P2093
P2860
P304
P356
10.3892/IJMM.2011.870
P577
2011-12-28T00:00:00Z